Cargando…
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
Infections are the primary cause of morbidity and mortality in multiple myeloma (MM) patients (pts). The aim of our retrospective analysis was to evaluate incidence and course of COVID-19 infection in a cohort of 351 MM outpatients treated with novel drugs. COVID-19 disease was detected in 50/351 pt...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310901/ https://www.ncbi.nlm.nih.gov/pubmed/34309714 http://dx.doi.org/10.1007/s00277-021-04594-w |